Which anti-VEGF agents are used in the treatment of choroidal neovascularization (CNV)?

Updated: Jul 27, 2020
  • Author: Lihteh Wu, MD; Chief Editor: Andrew A Dahl, MD, FACS  more...
  • Print

Intravitreal ant-VEGF agents used for the treatment of CNV include the following:

  • Pegaptanib sodium [8]
  • Ranibizumab
  • Bevacizumab (off-label)
  • Aflibercept

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!